"Designing Growth Strategies is in our DNA"

Neuroendocrine Tumors Treatment Market Size, Share and Global Trend By Therapy (Somatostatin Analogues, Chemotherapy, Immunotherapy), By Disease Indication (Lung Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast, 2024-2032

Region : Global | Report ID: FBI100715 | Status : Ongoing



The global burden of tumors is increasing at a significant rate globally. Neuroendocrine tumors (NET) are a rare type of tumors that arise from the cells of the endocrine/hormonal system and the nervous system. Neuroendocrine tumors mostly arise in the intestinal system where they are referred to as carcinoid tumors but can also arise in other parts of the body such as appendix, rectum, pancreas, and lungs. In terms of nature, neuroendocrine tumors can be either be benign or cancerous. Neuroendocrine tumors are broadly classified into two categories namely, carcinoid tumors (arising in the appendix, digestive tract, lungs or lymph nodes, amongst others) and pancreatic neuroendocrine tumors (arising in islet cells of the pancreas).

The symptoms of neuroendocrine tumors include constipation, diarrhea, tummy pains, persistent coughing, low blood sugar, and changes in blood pressure, cardiac issues, and others. The rising prevalence of neuroendocrine tumors is the major reason for the increased clinical studies and new product launch. In January 2018, Novartis AG received FDA approval for Lutathera, radiolabeled somatostatin analog for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), which is expected to augment the global neuroendocrine tumors treatment market.

To gain extensive insights into the market, Request for Customization

Primary reasons responsible for the growth in global neuroendocrine tumors treatment market are rising prevalence of neuroendocrine tumors, increasing R&D investment, new product launch, and early diagnosis due to advanced diagnostic technique. According to the American Society for Clinical Oncology (ASCO), more than 12,000 individuals in the U.S. are diagnosed with neuroendocrine tumors every year, which is expected to fuel global neuroendocrine tumors treatment market.

The factors limiting the growth of the global neuroendocrine tumors treatment market are stringent government regulations, late diagnosis of neuroendocrine tumors, and associated side effects of the treatment options.

Key Players Covered

Some of the major companies that are present in the global neuroendocrine tumors treatment market are Novartis AG, Pfizer Inc., Ipsen Pharma, Advanced Accelerator Applications, Tarveda Therapeutics, Boehringer Ingelheim International GmbH, Progenics Pharmaceuticals, Inc., AVEO Pharmaceuticals, Inc., and Hutchison MediPharma Limited.




By Therapy

· Somatostatin Analogues

· Chemotherapy

· Targeted Therapy

· Immunotherapy

· Others

By Disease Indication

· Gastrointestinal Neuroendocrine Tumor

· Lung Neuroendocrine Tumor

· Pancreatic Neuroendocrine Tumor

· Others

By Route of Administration

· Oral

· Parenteral

By Distribution Channel

· Hospital Pharmacy

· Retail Pharmacy

· Online Pharmacy

By Geography

· North America (USA and Canada)

· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

· Latin America (Brazil, Mexico and Rest of Latin America)

· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


Among the therapy, the chemotherapy segment is anticipated to account for a major portion of the market during the forecast period as its is used as the first line of treatment for tumors owing to its more preference among healthcare providers and patients.

Key Insights

  • Prevalence of neuroendocrine tumors for key countries
  • The regulatory scenario for key countries
  • Reimbursement Scenario for key countries
  • New product launch
  • Patent analysis
  • Pipeline snapshot
  • Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis

North America is projected to dominate the global neuroendocrine tumors treatment market owing to the rapid adoption of targeted therapy, strategic presence of major manufacturers, increased government research grants on cancer. Also, the FDA approval for Afinitor for the treatment of patients with lung or gastrointestinal (GI) neuroendocrine tumors is anticipated to favor the neuroendocrine tumors treatment in North America. The growth in neuroendocrine tumors treatment market in Europe is likely to propel over the forecast duration due to the increased R&D spending, favorable health reimbursement, and strategic collaborations. Asia Pacific is estimated to register a remarkable growth in the global neuroendocrine tumors treatment market owing to the rising prevalence of neuroendocrine tumors and improving healthcare infrastructure.

Key Industry Developments

  • In January 2018, Novartis AG received FDA approval for Lutathera, radiolabeled somatostatin analog for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
  • In October 2017, Novartis AG announced the acquisition of Advanced Accelerator Applications, a radiopharmaceutical company in order to expand its oncology product portfolio.
  • In February 2016, Novartis AG received FDA approval for Afinitor, a targeted therapy for the treatment of both gastrointestinal (GI) and lung neuroendocrine tumors.

  • Ongoing
  • 2023
  • 2019-2022


  • $4850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients


Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.